This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, Z. Articles by Garabedian, M. J. Search for Related Content PubMed PubMed Citation Articles by Wang, Z. Articles by Garabedian, M. J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene

Modulation of Glucocorticoid Receptor Phosphorylation and Transcriptional Activity by a C-Terminal-Associated Protein Phosphatase

Departments of Microbiology (Z.W., E.K., T.D., M.J.G.), Urology (M.J.G.), and Pharmacology (W.C.), New York University Cancer Institute, New York University School of Medicine, New York, New York 10016

Address all correspondence and requests for reprints to: Michael J. Garabedian, Departments of Microbiology, Urology, New York University Cancer Institute, New York University School of Medicine, 550 First Avenue, New York, New York 10016. E-mail: garabm01{at}med.nyu.edu.

The glucocorticoid receptor (GR) is phosphorylated at three major sites on its N terminus (S203, S211, and S226), and phosphorylation modulates GR-regulatory functions in vivo. We examined the phosphorylation site interdependence, the contribution of the receptor C-terminal ligand-binding domain, and the participation of protein phosphatases in GR N-terminal phosphorylation and gene expression. We found that GR phosphorylation at S203 was greater when S226 was not phosphorylated and vice versa, indicative of intersite dependency. We also observed that a GR derivative lacking the ligand-binding domain, which no longer binds the heat shock protein 90 (Hsp90) complex, exhibits increased GR phosphorylation at all three sites as compared with the full-length receptor. A GR mutation (F602S) that produces a receptor less dependent on Hsp90 for function as well as treatment with the Hsp90 inhibitor geldanamycin also increased basal GR phosphorylation at a subset of sites. Pharmacological inhibition of serine/threonine protein phosphatases increased GR basal phosphorylation. Likewise, a reduction in protein phosphatase 5 protein levels enhanced GR phosphorylation at a subset of sites and selectively reduced the induction of endogenous GR target genes. Together, our findings suggest that GR undergoes a phosphorylation/dephosphorylation cycle that maintains steady-state receptor phosphorylation at a low basal level in the absence of ligand. Our findings also suggest that the ligand-dependent increase in GR phosphorylation results, in part, from the dissociation of a ligand-binding domain-linked protein phosphatase(s), and that changes in the intracellular concentration of protein phosphatase 5 differentially affect GR target gene expression.

NURSA Molecule Pages Link:

Nuclear Receptors:   GR

Ligands:   Dexamethasone

This article has been cited by other articles:

				A. Kotitschke, H. Sadie-Van Gijsen, C. Avenant, S. Fernandes, and J. P. Hapgood Genomic and Nongenomic Cross Talk between the Gonadotropin-Releasing Hormone Receptor and Glucocorticoid Receptor Signaling Pathways Mol. Endocrinol., November 1, 2009; 23(11): 1726 - 1745. [Abstract] [Full Text] [PDF]

				Y. Zhang, D. Y. M. Leung, S. K. Nordeen, and E. Goleva Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation J. Biol. Chem., September 4, 2009; 284(36): 24542 - 24552. [Abstract] [Full Text] [PDF]

				E. Goleva, L.-b. Li, and D. Y. M. Leung IFN-{gamma} Reverses IL-2- and IL-4-Mediated T-Cell Steroid Resistance Am. J. Respir. Cell Mol. Biol., February 1, 2009; 40(2): 223 - 230. [Abstract] [Full Text] [PDF]

				I. M. Adcock and P. J. Barnes Molecular Mechanisms of Corticosteroid Resistance Chest, August 1, 2008; 134(2): 394 - 401. [Abstract] [Full Text] [PDF]

				W. Chen, T. Dang, R. D. Blind, Z. Wang, C. N. Cavasotto, A. B. Hittelman, I. Rogatsky, S. K. Logan, and M. J. Garabedian Glucocorticoid Receptor Phosphorylation Differentially Affects Target Gene Expression Mol. Endocrinol., August 1, 2008; 22(8): 1754 - 1766. [Abstract] [Full Text] [PDF]

				L. Davies, N. Karthikeyan, J. T. Lynch, E.-A. Sial, A. Gkourtsa, C. Demonacos, and M. Krstic-Demonacos Cross Talk of Signaling Pathways in the Regulation of the Glucocorticoid Receptor Function Mol. Endocrinol., June 1, 2008; 22(6): 1331 - 1344. [Abstract] [Full Text] [PDF]

				F. Jeanneteau, M. J. Garabedian, and M. V. Chao Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect PNAS, March 25, 2008; 105(12): 4862 - 4867. [Abstract] [Full Text] [PDF]

				N. L. Weigel and N. L. Moore Steroid Receptor Phosphorylation: A Key Modulator of Multiple Receptor Functions Mol. Endocrinol., October 1, 2007; 21(10): 2311 - 2319. [Abstract] [Full Text] [PDF]